PharmX Technologies Renews National Diabetes Services Scheme Agreement for 12 Months

MT Newswires Live

2025/07/11

PharmX Technologies (ASX:PHX) renewed its long-standing National Diabetes Services Scheme agreement, and a 12-month extension to the existing arrangement began July 1, according to a Friday Australian bourse filing.

It also secured partnerships with over 50 new suppliers across Australia and New Zealand during the fiscal year ended June 30, bringing the total number of active suppliers on its platform to over 170.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2550834609"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2550834609\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2550834609?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-11 14:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550834609","market":"nz","top_or_hot":-1,"title":"PharmX Technologies Renews National Diabetes Services Scheme Agreement for 12 Months","media":"MT Newswires Live","content":"<html><body><p> PharmX Technologies (ASX:PHX) renewed its long-standing <a href=\"https://laohu8.com/S/NHLD\">National</a> Diabetes Services Scheme agreement, and a 12-month extension to the existing arrangement began July 1, according to a Friday Australian bourse filing.</p><p>It also secured partnerships with over 50 new suppliers across <a href=\"https://laohu8.com/S/AN3PF.AU\">Australia and New Zealand</a> during the fiscal year ended June 30, bringing the total number of active suppliers on its platform to over 170.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PharmX Technologies Renews National Diabetes Services Scheme Agreement for 12 Months</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmX Technologies Renews National Diabetes Services Scheme Agreement for 12 Months\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-07-11 14:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> PharmX Technologies (ASX:PHX) renewed its long-standing <a href=\"https://laohu8.com/S/NHLD\">National</a> Diabetes Services Scheme agreement, and a 12-month extension to the existing arrangement began July 1, according to a Friday Australian bourse filing.</p><p>It also secured partnerships with over 50 new suppliers across <a href=\"https://laohu8.com/S/AN3PF.AU\">Australia and New Zealand</a> during the fiscal year ended June 30, bringing the total number of active suppliers on its platform to over 170.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7016","symbol_name":"應用軟件","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2550834609","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550834609","pubTimestamp":1752214553,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"PharmX Technologies  renewed its long-standing National Diabetes Services Scheme agreement, and a 12-month extension to the existing arrangement began July 1, according to a Friday Australian bourse filing.It also secured partnerships with over 50 new suppliers across Australia and New Zealand during the fiscal year ended June 30, bringing the total number of active suppliers on its platform to over 170.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7016":"应用软件","NHLD":"National Holdings Corporation","XKO.AU":"标普/澳交所 300指数","XJO.AU":"标普/澳交所 200指数","PHX.AU":"Pharmx Technologies Limited","XAO.AU":"标普/澳交所 普通股指数"},"translate_title":"PharmX Technologies续签国家糖尿病服务计划协议12个月","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAO.AU":0.9,"XKO.AU":0.9,"XJO.AU":0.9,"NHLD":1,"PHX.AU":0.9},"content_text":"PharmX Technologies (ASX:PHX) renewed its long-standing National Diabetes Services Scheme agreement, and a 12-month extension to the existing arrangement began July 1, according to a Friday Australian bourse filing.It also secured partnerships with over 50 new suppliers across Australia and New Zealand during the fiscal year ended June 30, bringing the total number of active suppliers on its platform to over 170.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}